Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients

C. C. Pao; W. L. Yang; S. Y. Wu; G. M. Lai; L. Y. Shih; C. F. Sun; Y. F. Liaw

doi:10.1128/jcm.25.2.449-451.1987

Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients

C. C. Pao
, W. L. Yang
, S. Y. Wu
, G. M. Lai
, L. Y. Shih
, C. F. Sun
, Y. F. Liaw

Research output: Contribution to journal › Journal Article › peer-review

7 Scopus citations

Abstract

We compared the prevalence of serum hepatitis B virus (HBV) DNA in cancer patients who were immunocompromised with that in healthy subjects. Testing positive for serum HBV DNA were 27 of the 232 (11.6%) surface-antigen-negative cancer patients and 7 of the 382 (1.8%) surface-antigen-negative healthy subjects. These data suggest that the negative serology, at least in immunocompromised individuals, is probably not sufficient to exclude HBV infection.

Original language	English
Pages (from-to)	449-451
Number of pages	3
Journal	Journal of Clinical Microbiology
Volume	25
Issue number	2
DOIs	https://doi.org/10.1128/jcm.25.2.449-451.1987
State	Published - 1987
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/jcm.25.2.449-451.1987

Cite this

@article{5f5fe34a2f02489485ce0b224414fe0f,

title = "Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients",

abstract = "We compared the prevalence of serum hepatitis B virus (HBV) DNA in cancer patients who were immunocompromised with that in healthy subjects. Testing positive for serum HBV DNA were 27 of the 232 (11.6\%) surface-antigen-negative cancer patients and 7 of the 382 (1.8\%) surface-antigen-negative healthy subjects. These data suggest that the negative serology, at least in immunocompromised individuals, is probably not sufficient to exclude HBV infection.",

author = "Pao, \{C. C.\} and Yang, \{W. L.\} and Wu, \{S. Y.\} and Lai, \{G. M.\} and Shih, \{L. Y.\} and Sun, \{C. F.\} and Liaw, \{Y. F.\}",

year = "1987",

doi = "10.1128/jcm.25.2.449-451.1987",

language = "英语",

volume = "25",

pages = "449--451",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients

AU - Pao, C. C.

AU - Yang, W. L.

AU - Wu, S. Y.

AU - Lai, G. M.

AU - Shih, L. Y.

AU - Sun, C. F.

AU - Liaw, Y. F.

PY - 1987

Y1 - 1987

N2 - We compared the prevalence of serum hepatitis B virus (HBV) DNA in cancer patients who were immunocompromised with that in healthy subjects. Testing positive for serum HBV DNA were 27 of the 232 (11.6%) surface-antigen-negative cancer patients and 7 of the 382 (1.8%) surface-antigen-negative healthy subjects. These data suggest that the negative serology, at least in immunocompromised individuals, is probably not sufficient to exclude HBV infection.

AB - We compared the prevalence of serum hepatitis B virus (HBV) DNA in cancer patients who were immunocompromised with that in healthy subjects. Testing positive for serum HBV DNA were 27 of the 232 (11.6%) surface-antigen-negative cancer patients and 7 of the 382 (1.8%) surface-antigen-negative healthy subjects. These data suggest that the negative serology, at least in immunocompromised individuals, is probably not sufficient to exclude HBV infection.

UR - https://www.scopus.com/pages/publications/0023140041

U2 - 10.1128/jcm.25.2.449-451.1987

DO - 10.1128/jcm.25.2.449-451.1987

M3 - 文章

C2 - 3818937

AN - SCOPUS:0023140041

SN - 0095-1137

VL - 25

SP - 449

EP - 451

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 2

ER -

Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this